Phthalimide → N-[[1-(tert-Butoxycarbonyl)perhydroazepin-3-yl]methyl]phthalimide
反応式
[C:1]([O:5][C:6]([N:8]1[CH2:14][CH2:13][CH2:12][CH2:11][CH:10]([CH2:15]O)[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[C:36]1(=[O:46])[NH:40][C:39](=[O:41])[C:38]2=[CH:42][CH:43]=[CH:44][CH:45]=[C:37]12.N(C(OCC)=O)=NC(OCC)=O>O1CCCC1.O.C1(C)C=CC=CC=1>[C:1]([O:5][C:6]([N:8]1[CH2:14][CH2:13][CH2:12][CH2:11][CH:10]([CH2:15][N:40]2[C:39](=[O:41])[C:38]3=[CH:42][CH:43]=[CH:44][CH:45]=[C:37]3[C:36]2=[O:46])[CH2:9]1)=[O:7])([CH3:2])([CH3:3])[CH3:4]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
1-(tert-Butoxycarbonyl)perhydroazepin-3-yl methanol (1.13 g, 4.93 mmol) was dissolved in tetrahydrofuran (10 mL). To this solution, triphenylphosphine (1.60 g, 5.92 mmol) and phthalimide (871 mg, 5.92 mmol) were added and the mixture was stirred at room temperature for 5 min. A 40% toluene solution of diethyl azodicarboxylate (3.23 mL, 7.40 mmol) was then added and the mixture was stirred at room temperature for 4 hours. Subsequently, water was added and the mixture was extracted with ethyl acetate. The extract washed with brine and was dried over magnesium sulfate, followed by evaporation of the solvent. Purification of the residue by silica gel column chromatography (hexane:ethyl acetate=10:1->2:1) gave 1.27 g (72%) of the desired compound as a colorless powder.
後処理
- stirringthe mixture was stirred at room temperature for 4 hours
- extractionthe mixture was extracted with ethyl acetate
- washThe extract washed with brine
- dry with materialwas dried over magnesium sulfate
- customfollowed by evaporation of the solvent
- customPurification of the residue by silica gel column chromatography (hexane:ethyl acetate=10:1->2:1)
出典と根拠
- ORDレコード
- ord-5a699c5b9dd144ba9de0c8e26f7334a9
- 出典データセット
- uspto-grants-2011_03
- 特許番号
- US07902367B2
反応ノート
読み込み中…